Prolactin Test · Blood

If your periods have gone missing, your libido has dropped for no clear reason, or you have been struggling with unexplained infertility, there is a good chance no one has checked your prolactin. This single number reflects how active the hormone-producing cells in your pituitary gland are, and when it drifts too high, it can shut down ovulation, suppress sex hormones, and quietly thin your bones, sometimes for years before anyone connects the dots.

Prolactin (PRL) is best known for triggering breast milk production after childbirth, but your body uses it for far more than lactation. It influences how your immune system behaves, how your fat tissue handles insulin, and how your brain processes pain. A single blood test can reveal whether this hormone is in balance or whether something, a pituitary growth, a medication, or a stress response, is pushing it off course.

What Prolactin Does in Your Body

Prolactin is a small protein hormone, 199 amino acids long, made mainly by specialized cells called lactotrophs in the anterior pituitary, a pea-sized gland at the base of your brain. Smaller amounts are produced in breast tissue, the uterus, fat cells, and immune cells, where prolactin acts locally rather than traveling through the bloodstream.

The brain keeps prolactin in check through dopamine, a chemical messenger released by neurons in the hypothalamus, the brain region that coordinates hormonal signals. Dopamine constantly signals the pituitary to hold back prolactin release. When that brake weakens, whether from a pituitary tumor, a dopamine-blocking drug, or severe stress, prolactin levels climb. This is why the most effective treatments for high prolactin work by mimicking dopamine.

Prolactin's reach extends well beyond the breast. It helps regulate the hormonal cascade that drives ovulation, modulates immune cell activity, and appears to influence how fat tissue responds to insulin. Because its receptor is found in so many tissues, abnormal levels can ripple across multiple body systems simultaneously.

Fertility and Reproductive Health

Hyperprolactinemia, meaning a persistently elevated prolactin level, is one of the most common hormonal causes of anovulation (failure to release an egg) and infertility in women. When prolactin stays too high, it suppresses the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn reduces FSH (follicle-stimulating hormone) and LH (luteinizing hormone). The result: periods become irregular or stop altogether, and conception becomes difficult or impossible.

In men, the consequences are different but equally disruptive. Elevated prolactin can lower testosterone, reduce sex drive, cause erectile dysfunction, and in some cases lead to breast tissue growth or milk discharge. A study screening 1,022 men with erectile dysfunction found that prolactin testing was most productive when combined with low libido, breast changes, or low testosterone, rather than as a blanket test for all men with ED.

If you have been told your FSH (follicle-stimulating hormone), LH (luteinizing hormone), estradiol, or testosterone levels are low without an obvious explanation, an unchecked prolactin elevation may be the upstream cause. Treating the prolactin problem often restores the entire hormonal chain.

Breast Cancer Risk

Several large, long-running studies have examined whether circulating prolactin levels predict future breast cancer. The evidence points to a modest but consistent link, especially for estrogen-receptor-positive (ER+) tumors in postmenopausal women.

Sources: Kresovich et al. 2024 (pooled 4 cohorts); Tworoger et al. 2013 (20-year NHS); Tworoger et al. 2007 (pooled NHS/NHSII).

What this means for you: the risk increase is real but modest. A woman in the top quarter of prolactin levels has roughly a 20 to 30% higher chance of developing breast cancer compared to a woman in the bottom quarter, not a doubling of risk. The association is strongest when prolactin is measured relatively close to diagnosis (within 10 years) and weakens for blood drawn more than a decade before. If you have other breast cancer risk factors, such as family history, dense breast tissue, or long-term hormone therapy, knowing your prolactin level adds a useful piece to the picture.

Type 2 Diabetes: A Surprising Twist

Most of prolactin's disease links go in one direction: higher levels, higher risk. Diabetes breaks the pattern. Among more than 8,600 generally healthy US women followed for up to 22 years, those in the highest quarter of normal-range prolactin had a 27% lower risk of developing type 2 diabetes compared to those in the lowest quarter (HR 0.73). The protective association was strongest within the first 9 to 10 years after the blood draw.

A separate meta-analysis combining cross-sectional and cohort data confirmed the pattern. People with the lowest prolactin levels were roughly twice as likely to have type 2 diabetes as those with the highest levels in cross-sectional studies. In women followed over time, the lowest prolactin group had about 52% higher odds of developing diabetes.

Meanwhile, in a different population, 10,907 people who already had type 2 diabetes, higher prolactin predicted worse outcomes. Those with the highest prolactin levels had about 49% higher all-cause mortality and roughly 2.4 times the cardiovascular death rate compared to those with the lowest levels.

These findings are not contradictory once you understand the framework. Prolactin is not a simple "higher is better" or "lower is better" marker. Within the healthy range, adequate prolactin appears to support how your fat tissue and pancreas handle insulin. But when prolactin climbs above normal, whether from a pituitary growth, kidney disease, or medication, it signals or contributes to a stressed metabolic and cardiovascular system. Think of it as a Goldilocks hormone: too little and too much are both informative, but they point to different problems.

Heart Health and Mortality

A 2024 meta-analysis pooling 14 studies and 23,596 adults without prolactin-secreting tumors found that each incremental rise in prolactin was associated with about a 17% increase in the risk of dying from any cause and about a 54% increase in cardiovascular death risk. People in the highest prolactin category had roughly 80% higher all-cause mortality and about 60% higher cardiovascular mortality compared to those in the lowest category. These associations held after adjusting for standard risk factors.

In people with chronic kidney disease (CKD), the signal was even stronger. Among 457 patients with CKD not on dialysis, each 10 ng/mL increase in prolactin was linked to a 27% higher rate of cardiovascular events. Among 173 patients on hemodialysis, the same increment was associated with a 12% higher rate of death from any cause and a 15% higher rate of cardiovascular death. These links persisted even after accounting for blood vessel stiffness and function.

If your prolactin is elevated and you have other cardiovascular risk factors, such as high blood pressure, diabetes, or kidney disease, this combination may warrant closer monitoring and a conversation with a cardiologist or endocrinologist.

Bone Health

Chronic hyperprolactinemia weakens bones through two routes. First, by suppressing GnRH and reducing estrogen or testosterone, it creates a state of hormone deficiency similar to early menopause or low sex hormones in men. Second, research suggests prolactin may directly affect the cells that build and break down bone. The result is progressive bone thinning that can lead to osteopenia or osteoporosis, especially when elevated prolactin goes untreated for years.

If your prolactin has been high for a prolonged period, a bone density scan (DEXA) is a reasonable next step, regardless of your age or sex.

Reference Ranges

Prolactin reference ranges depend heavily on the specific laboratory testing system and whether the lab screens for macroprolactin, a biologically inactive form of the hormone that can inflate your result. A study validating reference intervals across six major lab testing systems found that upper limits for the active form of prolactin after removing macroprolactin ranged from about 9 to 14 ng/mL in men and about 13 to 22 ng/mL in women, depending on the analyzer.

The following table provides general orientation based on published data. Your lab's printed range may differ, and you should always interpret your result against the range on your own report.

A level above 200 to 250 ng/mL strongly suggests a prolactin-secreting pituitary tumor (prolactinoma), and the number generally correlates with tumor size. Mild elevations below 100 ng/mL have many possible causes, including stress, medications, and macroprolactin, and require careful interpretation before assuming a tumor.

When Results Can Be Misleading

• Macroprolactin: This is the single biggest trap. Macroprolactin is a large, biologically inactive form of the hormone that many standard lab tests count as if it were active prolactin. In one large audit, about 22% of samples flagged as hyperprolactinemic turned out to be macroprolactinemia with no symptoms and no need for treatment. If your prolactin is elevated but you have no symptoms, ask your lab to run a macroprolactin screen (also called PEG precipitation).
• Stress and the blood draw itself: The act of having blood drawn can itself raise prolactin. In a study of 757 patients referred for elevated prolactin, 66% normalized when retested under calm, rested conditions using an indwelling catheter. Simple needle anxiety or rushing to the lab can produce a false alarm.
• Time of day and sleep: Prolactin peaks during sleep and in the early morning hours. Drawing blood later in the morning after a calm arrival produces the most reliable baseline reading.
• Medications (not causing true hyperprolactinemia): Antidepressants (SSRIs, tricyclics, MAOIs) can mildly raise prolactin, usually within or just above the normal range, without causing pituitary disease. H2 blockers like cimetidine and certain blood pressure medications (methyldopa, verapamil) can also shift the number. If you are on any of these, mention them when interpreting results.
• The hook effect: In very large prolactinomas, prolactin concentrations can be so high that the lab test paradoxically reports a normal or mildly elevated value. If you have a large pituitary mass and a surprisingly low prolactin reading, your doctor should request a diluted sample to unmask the true level.

Tracking Your Trend

A single prolactin reading is more like a snapshot taken mid-conversation than a finished portrait. Within-person biological variation for prolactin is high, roughly 58% over a year in healthy women, and the reliability of a single measurement is only moderate in premenopausal women (a reliability score of about 0.48 out of 1.0) compared to good reliability in postmenopausal women (about 0.76). This means two readings from the same person, taken months apart under identical conditions, can differ substantially.

For a meaningful picture, get your baseline, then retest in 4 to 8 weeks if the first result is abnormal, using the same lab and the same collection protocol (morning, fasting, rested). If you are being treated for a prolactinoma or monitoring a medication's effect, check prolactin every 3 to 6 months until stable, then at least annually. Always compare results within the same lab and testing system, because cross-lab variation for prolactin can be as high as 28%.

Trending is especially valuable if you are taking a medication known to raise prolactin. A rising trend over several measurements is more informative than any single number for deciding whether a dose change or medication switch is warranted.

What to Do With an Abnormal Result

If your prolactin comes back elevated, resist the urge to assume the worst. Follow this decision pathway:

• Mildly elevated (just above your lab's upper limit): Retest under standardized conditions, morning, fasting, calm, same lab. Request macroprolactin screening. Review your medication list for anything that raises prolactin (antipsychotics, antidepressants, anti-nausea drugs, certain blood pressure medications). If the repeat is normal, you likely had a stress-related or testing artifact.
• Persistently elevated (confirmed on repeat, macroprolactin ruled out): Check TSH (thyroid-stimulating hormone) to rule out hypothyroidism as a cause. Check kidney function, since CKD raises prolactin. If no medication or systemic cause is found, pituitary MRI is the next step to look for a benign pituitary growth (adenoma).
• Above 100 ng/mL with no obvious drug cause: This strongly suggests a prolactinoma. Referral to an endocrinologist is appropriate. Levels above 200 to 250 ng/mL almost always indicate a macroprolactinoma (a larger pituitary tumor), which may also cause headaches or vision changes from pressure on nearby structures.
• Unexpectedly normal with a large pituitary mass: Ask for a diluted sample to check for the hook effect, where very high concentrations paradoxically read as normal on standard tests.

Companion tests that help build the full picture include FSH (follicle-stimulating hormone), LH (luteinizing hormone), estradiol or testosterone (depending on sex), TSH, and a kidney function panel. If a prolactinoma is confirmed, an endocrinologist will guide treatment, which typically starts with a dopamine agonist medication (a drug that mimics dopamine to suppress prolactin) rather than surgery.